- by John Reints
- Jan 8 2026
Drug Safety Monitoring: How the FDA Watches Generics After Approval
The FDA doesn't stop monitoring generic drugs after approval. Learn how it uses real-time data, inspections, and reporting systems to catch hidden risks and keep millions of patients safe.